1. Katz Sand I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol. 2015;28(3):193-205.
2. Britze J, Frederiksen JL. Optical coherence tomography in multiple sclerosis. Eye (London, England). 2018;32(5):884-888. doi:10.1038/s41433-017-0010-2
3. Lanzillo R, Cennamo G, Criscuolo C, et al. Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis. Multiple Sclerosis. 2018;24(13):1706-1714. doi:10.1177/ 1352458517729463
4. Naumovska M, Sheikh R, Bengtsson B, Malmsjö M, Hammar B. Visual outcome is similar in optic neuritis patients treated with oral and i.v. high-dose methylprednisolone: a retrospective study on 56 patients. BMC Neurology. 2018;18(1):160. doi:10.1186/s12883-018-1165-6
5. Petzold A, Fraser CL, Abegg M, et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022;21(12):1120-1134. doi:10.1016/s1474-4422(22)00200-9
6. Trip SA, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage. 2006; 31(1):286-293. doi:10.1016/j.neuroimage.2005.11.051
7. Cheng H, Laron M, Schiffman JS, Tang RA, Frishman LJ. The relationship between visual field and retinal nerve fiber layer measurements in patients with multiple sclerosis. Invest Ophthalmol Vis Sci. 2007;48(12):5798-5805.
8. Khalil DH, Said MM, Abdelhakim MASE, Labeeb DM. OCT and visual field changes as useful markers for follow-up of axonal loss in multiple sclerosis in Egyptian patients. Ocul Immunol Inflamm. 2017; 25(3):315-322.
9. Cennamo G, Romano MR, Vecchio EC, et al. Anatomical and functional retinal changes in multiple sclerosis. Eye. 2016;30(3):456-462. doi:10.1038/eye.2015.256
10. Plumb J, McQuaid S, Mirakhur M, Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 2002;12(2):154-169. doi:10.1111/j.1750- 3639.2002.tb00430.x
11. Wang X, Jia Y, Spain R, et al. Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis. Br J Ophthalmol. 2014;98(10):1368-1373. doi:10.1136/bjophthalmol-2013- 304547
12. Ulusoy MO, Horasanlı B, Işık Ulusoy S. Optical coherence tomography angiography findings of multiple sclerosis with or without optic neuritis. Neurol Res. 2020;42(4):319-326. doi:10.1080/01616412.2020. 1726585
13. Farci R, Carta A, Cocco E, Frau J, Fossarello M, Diaz G. Optical coherence tomography angiography in multiple sclerosis: a cross-sectional study. PLoS One. 2020;15(7):e0236090. doi:10.1371/journal.pone.0236090
14. Mohammadi S, Gouravani M, Salehi MA, et al. Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis. J Neuroinflammation. 2023;20(1): 85. doi:10.1186/s12974-023-02763-4
15. Caprio M, Russo C, Giugliano A, Ragucci M, Mancini M. Vascular disease in patients with multiple sclerosis: a review. J Vasc Med Surg. 2016;4(2):746-753.
16. Akarsu C, Tan FU, Kendi T. Color Doppler imaging in optic neuritis with multiple sclerosis. Graefes Arch Clin Exp Ophthalmol. 2004; 242(12):990-994. doi:10.1007/s00417-004-0948-1